LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback